Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity
METADATA ONLY
Loading...
Author / Producer
Date
2020-08-21
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
METADATA ONLY
Data
Rights / License
Abstract
Mutating the side-chains of amino acids in a peptide ligand, with unnatural amino acids, aiming to mitigate its short half-life is an established approach. However, it is hypothesized that mutating specific backbone peptide bonds with bioisosters can be exploited not only to enhance the proteolytic stability of parent peptides, but also to tune its receptor subtype selectivity. Towards this end, four [Y]6-Angiotensin II analogues are synthesized where amide bonds have been replaced by 1,4-disubstituted 1,2,3-triazole isosteres in four different backbone locations. All the analogues possessed enhanced stability in human plasma in comparison with the parent peptide, whereas only two of them achieved enhanced AT2R/AT1R subtype selectivity. This diversification has been studied through 2D NMR spectroscopy and unveiled a putative more structured microenvironment for the two selective ligands accompanied with increased number of NOE cross-peaks. The most potent analogue, compound 2, has been explored regarding its neurotrophic potential and resulted in an enhanced neurite growth with respect to the established agent C21. © 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
36 (47)
Pages / Article No.
10690 - 10694
Publisher
Wiley-VCH
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Click chemistry; Competition-binding experiments; G-protein-coupled receptors; Neurotrophic effects; Peptidomimetics
Organisational unit
Notes
Funding
157076 - Verbessertes Tumor Targeting mit Radioaktiv-Markierten Peptidomimetika (SNF)